- March 15, 2022
- Newsletter
- 617-430-5616
Menu
Brand Name :
Cozaar
Synonyms :
Class :
Antihypertensives; Angiotensin Receptor Blockers
Dosage forms & Strengths:
Adult:
Tablet:
25 mg
50 mg
100 mg
Not recommended for children below 6 years
For children above 6 years:
0.7 mg/kg orally each day
angiotensin II Receptor Blockers may enhance the adverse/toxic effect of angiotensin-Converting Enzyme Inhibitors
angiotensin II Receptor Blockers may enhance the adverse/toxic effect of angiotensin-Converting Enzyme Inhibitors
angiotensin II Receptor Blockers may enhance the adverse/toxic effect of angiotensin-Converting Enzyme Inhibitors
angiotensin II Receptor Blockers may enhance the adverse/toxic effect of angiotensin-Converting Enzyme Inhibitors
angiotensin II Receptor Blockers may enhance the adverse/toxic effect of angiotensin-Converting Enzyme Inhibitors
may increase the hyperkalemic effect of aliskiren
may increase the adverse effect of angiotensin II receptor blockers
may enhance the serum concentration of angiotensin II receptor blockers
may increase the hyperkalemic effect of aliskiren
may increase the adverse effect of angiotensin ii receptor blockers
may increase the adverse effect of angiotensin ii receptor blockers
may increase the adverse effect of angiotensin ii receptor blockers
may increase the adverse effect of angiotensin ii receptor blockers
may increase the adverse effect of angiotensin ii receptor blockers
It may enhance the effect when combined with lonafarnib by affecting CYP3A4 metabolism
may diminish the therapeutic effect of angiotensin II Receptor Blockers
may diminish the therapeutic effect of angiotensin II Receptor Blockers
may diminish the therapeutic effect of angiotensin II Receptor Blockers
may diminish the therapeutic effect of angiotensin II Receptor Blockers
may diminish the therapeutic effect of angiotensin II Receptor Blockers
may enhance the risk of adverse/toxic effect of NSAIDs
may enhance the risk of adverse/toxic effect of NSAIDs
may enhance the risk of adverse/toxic effect of NSAIDs
may enhance the risk of adverse/toxic effect of NSAIDs
may enhance the risk of adverse/toxic effect of NSAIDs
may have an increased therapeutic effect when combined with angiotensin II receptor blocker
may have an increased therapeutic effect when combined with angiotensin II receptor blocker
may have an increased therapeutic effect when combined with angiotensin II receptor blocker
may have an increased therapeutic effect when combined with angiotensin II receptor blocker
may have an increased therapeutic effect when combined with angiotensin II receptor blocker
It may enhance the toxicity when combined with mipomersen
It may enhance the effects when combined with maitake by pharmacodynamic synergism
when both drugs are combined, there may be a decreased level of serum concentration of losartan
the effect of losartan is decreased by lorlatinib, by altering intestinal or hepatic CYP3A4 enzyme metabolism
it increases the effect or level of ruxolitinib by altering the intestinal or hepatic CYP3A4 enzyme metabolism
angiotensin II Receptor Blockers may enhance the hyperkalemic effect of potassium-Sparing Diuretics
angiotensin II Receptor Blockers may enhance the hyperkalemic effect of potassium-Sparing Diuretics
angiotensin II Receptor Blockers may enhance the hyperkalemic effect of finerenone
it increases the effect of hyperkalemia of angiotensin II receptor blockers
it increases the hypotensive effect of angiotensin II receptor blockers
it increases the hypotensive effect of angiotensin II receptor blockers
it increases the hypotensive effect of angiotensin II receptor blockers
it increases the effect of hyperkalemia of angiotensin II receptor blockers
angiotensin II receptor blockers increase the toxicity of NSAIDs
angiotensin II receptor blockers increase the toxicity of NSAIDs
angiotensin II receptor blockers increase the toxicity of NSAIDs
angiotensin II receptor blockers increase the toxicity of NSAIDs
angiotensin II receptor blockers increase the toxicity of NSAIDs
it increases the toxicity of angiotensin II receptor blockers
ACE Inhibitors may enhance the therapeutic effect of angiotensin II receptor antagonists
ACE Inhibitors may enhance the therapeutic effect of angiotensin II receptor antagonists
ACE Inhibitors may enhance the therapeutic effect of angiotensin II receptor antagonists
ACE Inhibitors may enhance the therapeutic effect of angiotensin II receptor antagonists
ACE Inhibitors may enhance the therapeutic effect of angiotensin II receptor antagonists
may increase the toxic effect of non-steroidal anti-inflammatory drugs
may enhance the hypotensive effect of angiotensin II receptor antagonist
may enhance the hypotensive effect of angiotensin II receptor antagonist
may enhance the hypotensive effect of angiotensin II receptor antagonist
may decrease the therapeutic effect of angiotensin-converting enzyme inhibitors
may decreases the therapeutic effect. Angiotensin receptor
may increase the toxic effect of nonsteroidal anti-inflammatory agents
may increase the hyperkalemic effect when combined with angiotensin II receptor blockers
drospirenone/ethinyl estradiol/levomefolate
may increase the hyperkalemic effect of Drospirenone-Containing Products
>10%:
Cough
1-10%:
Upper respiratory tract infection
Dizziness
Nasal congestion
Back pain
Frequency undefined:
Anemia
Depression
Somnolence
Migraine
Vertigo
Dyspnea
Nausea
Abdominal pain
Impotence
Edema
Urticaria
Myalgia
Tinnitus
Losartan is contraindicated in patients hypersensitive to the formulation’s active ingredient and other excipients.
Pregnancy consideration:
Not indicated for usage in pregnant women
Breastfeeding warnings:
The drug excretion in breastmilk is unknown
Pregnancy category:
Patient information leaflet
Generic Name: losartan
Pronounced: loh-sar-tan
Why do we use losartan?
Losartan treats hypertension and nephropathy associated with type 2 diabetes.